Insiders T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Delayed Nasdaq Other stock markets 02:34:44 2024-04-29 pm EDT			5-day change	1st Jan Change
2.91 ^USD	+2.46%		-7.91%	-53.63%

05:09pm	Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating	MT
Apr. 23	Top Premarket Decliners	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

T2 Biosystems, Inc. Announces the Resignation of Thierry Bernard as Class II Director and All Committees of the Board of Directors	Jan. 05	CI
T2 Biosystems, Inc. Announces Resignation of Alec Barclay as Chief Operations Officer, Effective November 30, 2022	22-11-07	CI
T2 Biosystems, Inc. Announces Board Appointments	22-04-28	CI
T2 Biosystems, Inc. Announces Management Changes	21-11-04	CI
T2 Biosystems, Inc Appoints Laura Adams to its Board of Directors	21-10-19	CI
T2 Biosystems, Inc. Announces Board Changes	21-07-23	CI
T2 Biosystems, Inc. Appoints Aparna Ahuja as Chief Medical Officer	21-01-07	CI
T2 Biosystems, Inc. Announces Board Changes	20-06-15	CI
T2 Biosystems, Inc. Promotes Tony Pare to Chief Commercial Officer	20-01-13	CI
T2 Biosystems, Inc. Appoints John Sperzel as Chief Executive Officer, President and Director	20-01-09	CI
T2 Biosystems, Inc. Announces Resignation of John McDonough as President and Chief Executive Officer	19-07-30	CI
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts	19-06-28	GL
T2 Biosystems, Inc. Announces Board Changes, Effective June 7, 2019	19-04-26	CI
T2 Biosystems, Inc. Announces Executive Changes	18-03-09	CI
T2 Biosystems, Inc. Names Darlene Deptula-Hicks as Senior Vice President and Chief Financial Officer	17-05-01	CI
T2 Biosystems, Inc. Announces Resignation of Shawn Lynch as Chief Financial Officer	17-03-08	CI
T2 Biosystems, Inc. Announces Resignation of Joshua Bilenker as Class II Director and from Nominating and Corporate Governance Committee	17-01-20	CI
T2 Biosystems, Inc. Elects Seymour Liebman as Director	16-09-22	CI
T2 Biosystems, Inc. Announces Resignation of Harry Wilcox as Director	16-09-07	CI
T2 Biosystems, Inc. Appoints Dr. Joanne Spadoro to Serve as Chief Operations Officer, Effective No Later Than September 6, 2016	16-07-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Insiders

Filters